Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZCCHC16 Activators

ZCCHC16 activators include a range of compounds that interact with various intracellular signaling pathways to ultimately increase the functional activity of ZCCHC16. The activation mechanisms involve several second messengers and kinases. Certain activators work by directly stimulating enzymes that increase the levels of cAMP within the cell, a second messenger known to regulate a plethora of cellular functions. If ZCCHC16 is responsive to this messenger, its activity could be enhanced. Another subset of activators operates through inhibition of phosphodiesterases, thus preventing the degradation of cAMP and possibly extending the activation of ZCCHC16 if it is influenced by the cAMP signaling pathway. Additionally, some compounds activate PKC, which could lead to phosphorylation events that increase ZCCHC16 activity, assuming the protein is regulated by PKC-mediated phosphorylation.

Other activators exert their effect by altering intracellular calcium levels, either through ionophores that directly increase calcium concentration or by inhibiting pathways that modulate calcium signaling. Elevated calcium may trigger a cascade of reactions, potentially involving ZCCHC16 if it is part of calcium-dependent signaling. Additionally, modulation of kinase signaling and changes in chromatin structure through the inhibition of histone deacetylases could lead to an upregulation of ZCCHC16 activity. Some compounds affect the Wnt signaling pathway by inhibiting GSK-3β, a key regulatory kinase within the pathway, which may indirectly influence ZCCHC16 activity. Others may increase ZCCHC16 activity by upregulating cGMP levels, assuming ZCCHC16 is regulated by cGMP-dependent signaling mechanisms.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

Non-specific inhibitor of phosphodiesterases leading to increased cAMP and potentially enhancing ZCCHC16 if it is cAMP-responsive.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Direct activator of protein kinase C (PKC) which might increase ZCCHC16 activity if the protein is regulated by PKC-mediated phosphorylation.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Calcium ionophore that elevates intracellular calcium levels, potentially activating ZCCHC16 if calcium signaling is involved.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Inhibits GSK-3β leading to activation of Wnt signaling which could indirectly increase ZCCHC16 activity if it is involved in this pathway.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

Antioxidant that modulates kinase signaling pathways, possibly enhancing ZCCHC16 activity through indirect kinase interactions.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

Calcium ionophore that increases intracellular Ca2+ levels, which might activate ZCCHC16 if it is regulated by calcium signaling.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

cAMP analog that activates PKA, potentially increasing ZCCHC16 activity if it is downstream of PKA-mediated phosphorylation.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

Histone deacetylase inhibitor which could upregulate ZCCHC16 through changes in chromatin structure and gene expression.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Phosphodiesterase 4 inhibitor, elevating cAMP levels and possibly enhancing ZCCHC16 if involved in cAMP-dependent signaling pathways.

Zaprinast (M&B 22948)

37762-06-4sc-201206
sc-201206A
25 mg
100 mg
$105.00
$250.00
8
(2)

Inhibits PDE5 leading to increased cGMP levels which could activate ZCCHC16 if cGMP-dependent signaling pathways are relevant.